David Jin
Overview
David Jin received $260K in total compensation at AVENUE THERAPEUTICS in 2023. David Jin also received an average of $1M at Fortress Biotech between 2022 and 2023 and an average of $512K at Avalon GloboCare Corp. from 2017 to 2023.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
Avalon GloboCare Corp.Chief Executive Officer
AVENUE THERAPEUTICSInterim Chief Financial Officer and Chief Operating Officer
Fortress BiotechChief Financial Officer and Head of Corporate Development
Avalon GloboCare Corp.Chief Executive Officer
Fortress BiotechChief Financial Officer and Head of Corporate Development
Avalon GloboCare Corp.CEO
Avalon GloboCare Corp.CEO
Avalon GloboCare Corp.CEO
Avalon GloboCare Corp.CEO
Avalon GloboCare Corp.CEO
Related executives
We found 14 more executives who work or worked at AVENUE THERAPEUTICS, Fortress Biotech, andAvalon GloboCare Corp..
Alexandra MacLean
AVENUE THERAPEUTICS
Chief Executive Officer
Lindsay Rosenwald
Fortress Biotech
Chief Executive Officer
Michael Weiss
Fortress Biotech
Chairman
Luisa Ingargiola
Avalon GloboCare Corp.
Chief Financial Officer
Meng Li
Avalon GloboCare Corp.
Chief Operating Officer
Lucy Lu
AVENUE THERAPEUTICS
Chief Executive Officer
Joseph Vazzano
AVENUE THERAPEUTICS
Chief Financial Officer
Yu Zhou
Avalon GloboCare Corp.
Chief Executive Officer
News
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2023 pay stays at $350K
August 28, 2024
AVENUE THERAPEUTICS CEO Alexandra MacLean's 2023 pay jumps 304% to $1.2M
May 3, 2024
Fortress Biotech CFO David Jin's 2023 pay jumps 267% to $1.3M
April 5, 2024
Avalon GloboCare Corp. CEO David Jin's 2022 pay stays at $360K
September 8, 2023
Avalon GloboCare Corp. CEO David Jin's 2021 pay falls 64% to $360K
November 21, 2022
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2020 pay slips 20% to $1.1M
December 13, 2021
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2019 pay rises 3% to $1.3M
June 22, 2020
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2018 pay jumps 34% to $1.3M
June 17, 2019